• The Grade
  • Posts
  • 💽 Arm is poised for upside says Morgan Stanley

💽 Arm is poised for upside says Morgan Stanley

While "This is Money" has a healthcare stock tip.

Author

Nick Barber
July 22, 2024

💬”What an insane decade it’s been this week.” Michael Weiss

ANALYST STOCK TIPS
Morgan Stanley thinks Arm is a good pick.

Arm, the semiconductor giant, was upgraded by Morgan Stanley with a price target of $190 - representing a 17% upside over its current price.

Arm's power efficient compute architecture, huge developer community and breadth of offering gives it centrality within edge AI.

Accenture was upgraded to buy by UBS with a price target of $400, representing a 22% upside over its current price. They are positive about Accenture’s potential for future growth given it has been beefing up its capabilities in artificial intelligence, cloud, digital transformation and cybersecurity. This should, according to analyst Kevin McVeigh, lead to “higher and more durable growth”.

The company has reported nearly $2 billion in generative AI bookings for the fiscal quarter ending in May 2024. This is a big jump - in the full fiscal year ending in August 2023 it only booked $300 million.

PRESS STOCK TIPS
This is Money: OptiBiotix Could Be the Natural Rival to Ozempic

Joanne Hart at This is Money thinks she may have found a blockbuster future potential obesity treatment. OptiBiotix, based in York, UK, has developed SlimBiome, a natural product similar to Ozempic. SlimBiome aids in weight loss, reduces blood pressure, boosts mood, and improves gut health by suppressing cravings. It's available from various retailers, including Amazon and Holland & Barrett. OptiBitotix has now also struck deals with Tata Group and Costco, and with a global launch planned for next year, SlimBiome could be set to make a significant impact. It has no side effects and is more affordable than medical alternatives, presenting a strong potential for OptiBiotix’s shares to rise.

“If the world wakes up to its potential, OptiBiotix shares, now 15p, should soar”.

NEWS
The Week Ahead.

  • Tuesday - Alphabet, Tesla, Coca-Cola, General Motors, Philip Morris International, Spotify and Visa release earnings.

  • Wednesday - AT&T, CME Group, Thermo Fisher Scientific, Ford, IBM and ServiceNow release earnings.

  • Thursday - The US releases its second-quarter growth figures. Analysts expect a modest 1.8% growth rate. AbbVie will also release its earnings.